Lim S, Jatakanon A, Gordon D, Macdonald C, Chung K F, Barnes P J
National Heart and Lung Institute, Imperial College School of Medicine and Royal Brompton Hospital, London SW3 6LY, UK.
Thorax. 2000 Oct;55(10):837-41. doi: 10.1136/thorax.55.10.837.
Theophylline is widely used in the treatment of asthma, and there is evidence that theophylline has anti-inflammatory or immunomodulatory effects. A study was undertaken to determine whether theophylline added to low dose inhaled steroids would be as efficacious as high dose inhaled steroids in asthma.
In a study in general practice of 155 recruited asthmatic patients with continuing symptomatic asthma while on 400 microgram beclomethasone dipropionate (BDP) daily and inhaled beta(2) agonist as required, the effect of (1) continuing low dose inhaled steroids alone (LDS, 200 microgram BDP twice daily), (2) low dose inhaled steroids plus low dose theophylline (LDT, 400 mg daily), or (3) high dose inhaled steroids (HDS, 500 microgram BDP) over a six month period was examined.
One hundred and thirty patients completed the study. Between group comparison using analysis of variance showed no overall differences in peak flow measurements, diurnal variation, and symptom scores. Changes in evening peak flows approached significance at the 5% level (p=0.077). The mean improvement in evening peak flow in the LDT compared with the LDS group was 20.6 l/min (95% confidence interval (CI) -2.5 to 38.8). In the LDT group there was an increase in evening peak flows at the end of the study compared with entry values (22.5 l/min), while in the LDS and HDS groups evening peak flows increased by 1.9 and 8.3 l/min, respectively. There was no significant difference in exacerbations or in side effects.
There were no overall significant differences between the low dose steroid, low dose steroid with theophylline, and the high dose steroid groups. The greatest within-group improvement in evening peak flows was found after theophylline. A larger study may be necessary to show significant effects.
茶碱广泛应用于哮喘治疗,且有证据表明茶碱具有抗炎或免疫调节作用。开展了一项研究以确定在低剂量吸入性糖皮质激素中添加茶碱是否与高剂量吸入性糖皮质激素治疗哮喘的效果相同。
在一项全科医疗研究中,招募了155例持续有症状的哮喘患者,这些患者每天使用400微克二丙酸倍氯米松(BDP)并按需吸入β₂激动剂,研究考察了(1)单独持续使用低剂量吸入性糖皮质激素(LDS,每日200微克BDP,分两次使用)、(2)低剂量吸入性糖皮质激素加低剂量茶碱(LDT,每日400毫克)或(3)高剂量吸入性糖皮质激素(HDS,500微克BDP)在六个月期间的效果。
130例患者完成了研究。使用方差分析进行组间比较显示,在峰值流速测量、日变化和症状评分方面无总体差异。夜间峰值流速的变化在5%水平接近显著性(p = 0.077)。与LDS组相比,LDT组夜间峰值流速的平均改善为20.6升/分钟(95%置信区间(CI)-2.5至38.8)。在LDT组中,研究结束时夜间峰值流速相对于初始值有所增加(22.5升/分钟),而在LDS组和HDS组中,夜间峰值流速分别增加了1.9升/分钟和8.3升/分钟。在病情加重或副作用方面无显著差异。
低剂量糖皮质激素组、低剂量糖皮质激素加茶碱组和高剂量糖皮质激素组之间无总体显著差异。在使用茶碱后,组内夜间峰值流速的改善最为明显。可能需要进行更大规模的研究以显示显著效果。